Cargando…
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer
Poly (ADP-ribose) polymerase (PARP) inhibitors exert their efficacy via synthetic lethal effects and by inducing cGAS/STING-mediated immune responses. We demonstrate that compared to monotherapies, combined PARP inhibition and STING agonism results in increased STING pathway activation, greater cyto...
Autores principales: | Pantelidou, Constantia, Jadhav, Heta, Kothari, Aditi, Liu, Renyan, Wulf, Gerburg M., Guerriero, Jennifer L., Shapiro, Geoffrey I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448789/ https://www.ncbi.nlm.nih.gov/pubmed/36068244 http://dx.doi.org/10.1038/s41523-022-00471-5 |
Ejemplares similares
-
Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
por: Patterson-Fortin, Jeffrey, et al.
Publicado: (2023) -
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer
por: Wang, Qiwei, et al.
Publicado: (2022) -
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
por: Ding, Liya, et al.
Publicado: (2023) -
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
por: Ding, Liya, et al.
Publicado: (2018) -
STING agonism turns human T cells into interferon‐producing cells but impedes their functionality
por: Kuhl, Niklas, et al.
Publicado: (2023)